The lancet weight determines wheal diameter in response to skin prick testing with histamine by Andersen, Hjalte Holm et al.
   
 
Aalborg Universitet
The lancet weight determines wheal diameter in response to skin prick testing with
histamine
Andersen, Hjalte Holm; Lundgaard, Anna Charlotte; Sohrt Petersen, Anne ; Hauberg, Lise
Eun; Sharma, Neha ; Damkjær Hansen, Sofie ; Elberling, Jesper; Arendt-Nielsen, Lars
Published in:
P L o S One
DOI (link to publication from Publisher):
10.1371/journal.pone.0156211
Publication date:
2016
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Andersen, H. H., Lundgaard, A. C., Sohrt Petersen, A., Hauberg, L. E., Sharma, N., Damkjær Hansen, S., ...
Arendt-Nielsen, L. (2016). The lancet weight determines wheal diameter in response to skin prick testing with
histamine. P L o S One, 11(5), [e0156211]. DOI: 10.1371/journal.pone.0156211
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: April 30, 2017
RESEARCH ARTICLE
The Lancet Weight Determines Wheal
Diameter in Response to Skin Prick Testing
with Histamine
Hjalte H. Andersen1, Anna Charlotte Lundgaard1☯, Anne S. Petersen1☯, Lise E. Hauberg1☯,
Neha Sharma1☯, Sofie D. Hansen1☯, Jesper Elberling2, Lars Arendt-Nielsen1*
1 SMI1, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg,
Denmark, 2 The Allergy Clinic, Copenhagen University Hospital, Gentofte, Copenhagen, Denmark
☯ These authors contributed equally to this work.
* LAN@hst.aau.dk
Abstract
Background
Skin prick test (SPT) is a common test for diagnosing immunoglobulin E-mediated allergies.
In clinical routine, technicalities, human errors or patient-related biases, occasionally results
in suboptimal diagnosis of sensitization.
Objective
Although not previously assessed qualitatively, lancet weight is hypothesized to be impor-
tant when performing SPT to minimize the frequency of false positives, false negatives, and
unwanted discomfort.
Methods
Accurate weight-controlled SPT was performed on the volar forearms and backs of 20
healthy subjects. Four predetermined lancet weights were applied (25 g, 85 g, 135 g and
265 g) using two positive control histamine solutions (1 mg/mL and 10 mg/mL) and one neg-
ative control (saline). A total of 400 SPTs were conducted. The outcome parameters were:
wheal size, neurogenic inflammation (measured by superficial blood perfusion), frequency
of bleeding, and the lancet provoked pain response.
Results
The mean wheal diameter increased significantly as higher weights were applied to the
SPT lancet, e.g. from 3.2 ± 0.28 mm at 25 g to 5.4 ± 1.7 mm at 265 g (p<0.01). Similarly,
the frequency of bleeding, the provoked pain, and the neurogenic inflammatory response
increased significantly. At 265 g saline evoked two wheal responses (/160 pricks) below
3 mm.
PLOSONE | DOI:10.1371/journal.pone.0156211 May 23, 2016 1 / 15
a11111
OPEN ACCESS
Citation: Andersen HH, Lundgaard AC, Petersen
AS, Hauberg LE, Sharma N, Hansen SD, et al.
(2016) The Lancet Weight Determines Wheal
Diameter in Response to Skin Prick Testing with
Histamine. PLoS ONE 11(5): e0156211. doi:10.1371/
journal.pone.0156211
Editor: Neil T Wright, Michigan State University,
UNITED STATES
Received: October 3, 2015
Accepted: May 3, 2016
Published: May 23, 2016
Copyright: © 2016 Andersen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Due to legal
restrictions imposed by Danish Law, subject data
obtained from experiments involving human
participants are available upon request. Interested
researchers may submit request for data to authors
HHA and LAN, hha@hst.aau.dk.
Funding: The authors received no specific funding
for this study.
Competing Interests: The authors have declared
that no competing interests exist.
Conclusion and clinical relevance
The applied weight of the lancet during the SPT-procedure is an important factor. Higher
lancet weights precipitate significantly larger wheal reactions with potential diagnostic impli-
cations. This warrants additional research of the optimal lancet weight in relation to SPT-
guidelines to improve the specificity and sensitivity of the procedure.
Introduction
Skin prick test (SPT) is the most commonly used test for diagnosing immunoglobulin E (IgE)-
mediated sensitization in asthma, allergic rhinitis and food allergy [1,2]. Collectively, these con-
ditions are, to a varying extend, affecting an estimated 25% of the entire western population
[3–7], thus warranting continuous optimization of related diagnostic tools and therapies. In
SPT reactions to introduced allergens, in sensitized individuals, IgE cross-links with the aller-
gens and binds to the receptor FcεRI on mast cells which in turn causes mast cell degranulation
with release of different inflammatory mediators such as histamine and mast cell proteases
[2,8]. Histamine stimulates the histamine-1 (H1) receptor on the endothelial cells and hista-
mine-2 (H2) receptors on smooth muscle resulting in a plasma extravasatory reaction known
as a wheal in the immediate surroundings of the penetration site [9]. Neurogenic inflammation
is a result of a secondary release of vasoactive substances from antidromically activated pepti-
dergic C-fibers [10–12]. The presence and extent of these local reactions (almost exclusively
the wheal) are widely used as the day-to-day diagnostic biomarkers for IgE-mediated allergies
[13].
SPT has advantages such as low cost, minimal invasiveness, rapidity of performance and
good diagnostic value when performed skillfully and in a standardized manner [1,14]. There is
a number of somewhat aligned guidelines for performing and interpreting SPT [13,15–18].
The present study follow the guidelines of the European Academy of Allergy and Clinical
Immunology (EAACI) [13,19]. A vital part of the SPT procedure is the use of both a positive
and a negative control [8]. These are included in the assay: to prove that the skin is capable of
producing a reaction [19], to assess whether reactivity to histamine is correlated with sensitivity
to the tested allergens [20], to detect insufficient lancet penetration leading to false negatives, to
brisk lancet handling resulting in false positives (false negative/positive IgE sensitization sta-
tus), and to prevent e.g. patients suffering from dermatographic urticaria from being falsely
diagnosed with an allergy [15,16,21]. In the positive control histamine dihydrochloride 10 mg/
mL is usually used to directly induce wheal and flare responses principally bypassing the
immunological system [13,22,23]. A negative control typically consists of the allergen solution
vehicle, most commonly glycerinated saline is applied [16].
It is well documented that skin reactivity measured by histamine- and allergen-induced skin
prick reaction varies considerably. This is likely in part related to subject-adhered factors such
as age [24,25], gender [26,27], concomitant medication [13,28], and seasonal variability
[26,29]. Besides the importance of the extract composition and potency, other SPT-influencing
factors are related to the technique itself, i.e. different procedures (including the practice of
adjustment to the histamine reactivity) [30–32], the chosen body region [26], the distance
between each skin pricks and the SPT lancet/device [1,33–37]. Lastly, the lancet weight utilized
during SPT is often cited as being an important parameter in the procedure [1,13,38], but little
evidence support this notion [39] and no attempts have been made at quantifying an appropri-
ate lancet weight range. Østerballe et Weeke (1979) and others [40,41] have examined the effect
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of the depth of the lancet pressed into the skin and found that the wheal size increased until the
prick depth reached 1 mm contributing to the design of the 1 mm tip shouldered standard SPT
lancet [40]. Following this, a number of studies have attempted to optimize the lancet design
but not accounted for lancet weight applied to the skin during the SPT [14,35,41]. Since it is
desirable to increase the diagnostic precision and reliability of the procedure, while decreasing
discomfort and incidents of bleedings [8,35,42], the present study explored the relationship
between the lancet weight applied during histamine SPT and wheal reactions in healthy volun-
teers with no history of allergy. Additionally, flare response intensity, prick-evoked pain, and
frequency of bleeding were monitored.
Methods
The study was designed to examine whether the lancet weight applied in SPT affects the wheal
and flare response, pain, and incidents of bleeding. Based on initial pilot studies using a range
of lancet weights, four different lancet weights where chosen; 25 g, 85 g, 135 g and 265 g. These
were applied repeatedly on the forearms and on the back of the 20 participating subject. Two
different histamine dihydrochloride concentrations were used; 1 mg/mL (equivalent to 0.1% or
5.43 mmol/L) and 10 mg/mL (equivalent to 1% or 5.43 mmol/L) as positive controls and a
saline solution similar to that of the two histamine solutions was used as a negative control. All
applied solutions (both histamine concentrations and the negative control solution) were 50%
glycerinated (0.9 g/L saline and 1.0 g/mL glycerin).
Subjects
In total 10 females and 10 males (age: 22.8 ± 2.2, range: 19–25 years) participated in one experi-
mental session lasting approximately two hours. Healthy females and males in the age of 18–60
years were eligible for enrolment in the study. The exclusion criteria were: any present or previ-
ous dermatological diseases and any history of allergy, pregnancy, drug addiction defined as
the use of cannabis, opioids or other drugs, previous neurologic, musculoskeletal or mental ill-
nesses, and lack of ability to communicate and/or cooperate. All the subjects had to sign the
declaration of consent before participating in the study. The study protocol was approved by
the local ethics committee of Region Nordjylland, Denmark (approval number: N-20140078).
Enrolment of subjects for study occurred between the 25th of January 2015 and the 9th of
March 2015.
Experimental setup
On the central volar aspects of the forearms eight squares with diagonals of 40 mmwere marked
with a metallic paint marker (054, Edding International GmbH, Germany) with a distance of 3
cm from the wrist and 3 cm from the antecubital fossae (see illustration of setup in S1 File).
This setup is in line with the European recommendations of SPT standardization [13]. For an
overview of the current European, American and Australian guidelines on the SPT procedure
and interpretation please refer to S1 Table. On the back 12 squares with diagonals of 40 mm
were marked with a metallic marker. Four squares were placed in a longitudinal line 20 mm lat-
eral to the vertebra on both sides. Lateral to the two lower squares, two identical squares were
marked. Droplets of histamine and saline were placed in the centre of each square. The concen-
trations of histamine were 1 mg/mL and 10 mg/mL (EAACI recommended positive control
[19]) and saline was used as a negative control (default preparations, Allergopharma, Diagenics,
Bletchley, UK). On the forearms of each subject a total of four histamine pricks and four saline
pricks were conducted and assessed whereas on the back a total of eight histamine pricks and
four saline pricks were conducted and assessed. In the entire experiment 400 weight-controlled
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skin pricks were conducted (for each subject: eight on the forearms, 12 on the back). All skin
pricks were conducted according to right-left mirrored proximal-distal allocation schedules in
which both anatomical location, order of applied weight and choice of solution was included.
The study was single-blinded so that the subjects were unaware whether histamine 10 mg/mL, 1
mg/mL or saline were being applied. Please refer to S1 Table for further on the setup and alloca-
tions schedules.
Performing the SPT
The pricks were performed with four different lancet weights; 25 g, 85 g, 135 g and 265 g. To
control the different lancet weights a SENSEBox transducer (Somedic, Hörby, Sweden) was
used. The setup provided a computerized weight profile output sampled at 100 Hz and was
manually calibrated before use. A sterile standard lancet with a 1 mm sharp tip and with hori-
zontal shoulders (Allergopharma, Diagenics, Bletchley, UK) was attached to the weight trans-
ducer using a custom made SPT lancet mount (Aalborg University, Aalborg, Denmark), see
Fig 1, below.
The lancet was pressed through a droplet of histamine or saline perpendicularly to the pre-
determined area of skin. This weight-monitoring approach resulted in a very consistent lancet
weight performance for each application lasting approximately 1.5–2 seconds, with a predeter-
mined peak intensity being applied for approximately 1 second. The exact peak lancet weight
was subsequently extracted from the weight profile output.
Fig 1. The setup of the SPT lancet attached to the SENSEBox Electronic von Frey weight transducer.
doi:10.1371/journal.pone.0156211.g001
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Physiological data
Ten minutes after the first prick was performed images were captured with a Dino-Lite Pro
digital dermascope polarizer with a resolution of 1.3 megapixel (Dino-Lite, Naarden, Holland)
to identify incidents of bleeding not readily visible by regular visual inspection. The speckle
contrast flowmetry (MoorFLPI, Moor Instruments, Devon, UK) were performed to measure
the mean superficial perfusion. The distance between the speckle contrast flowmetry and the
application area was 45 cm, the total exposure time was 8.3 ms and the gain setting was 150
units. The images from the speckle contrast flowmetry were analysed on appertaining software
(MoorFLPI Review V 4.0, Moor instruments) to assess the flare intensity within the predefined
squares. Using an averaged region of interest approach the mean superficial perfusion for each
square was found. Additionally, the diameters of the wheals were measured on the longitudinal
diameter and on the orthogonal midpoint diameter with a transparent ruler with mm resolu-
tion. One investigator measured the wheal diameters in the same order that the SPTs had been
applied and the lack of wheals, e.g. in response to saline was noted.
Psychophysical data
For each prick the evoked pain intensity rating was monitored using an electronic visual analog
scale (VAS); SENSEBox VAS (Somedic, Hörby, Sweden). The VAS-ratings were sampled at
100 Hz and the subjects were notified immediately before each skin prick. The modified VAS-
scale ranged from 0–100 mm where 0 mm indicated "no pain", 50 mm indicated "worst imagin-
able pain caused by a needle" and 100 mm indicated "worst imaginable pain". The individual
peak pain VAS-scores for each prick was extracted from the stimulus response curves.
Sub-experiment of SPT weight recordings in clinicians
SPT weight was sampled from four clinicians routinely working with SPT at the Allergy Clinic,
Gentofte Hospital, Gentofte, Copenhagen, Denmark. For lancet weight measurements the
setup shown on Fig 1 was reversed so that a 1.5 x 1.5 cm square of artificial suturing practice
skin (Aphelion Supplies Ltd., Birmingham, UK) was attached to the SENSEBox Electronic von
Frey weight transducer. The four clinicians were instructed to conduct a series of six skin
pricks, with standard 1mm lancets, resembling, as closely as possible, those applied on patients
in regular clinical routine. SPT weight profiles were sampled at 100 Hz and subsequently ana-
lysed for the peak weight value. It should be highlighted that these data are from a very limited
and potentially non-representative sample and merely attempts to preliminarily probe issues
pertaining to SPT lancet weight in the clinical routine.
Statistical analysis
Data handling and calculation of descriptive statistical parameters were conducted in Excel
(Microsoft, Redmond, Washington, USA). Further, statistical analyses were performed in SPSS
(IBM, Armonk, New York, USA). The graphical representations were created with GraphPad
Prism 6 (Graphpad Software, Inc, La Jolla, California, USA). Sample size calculations were con-
ducted based on previously obtained test-retest reliability data of responses to histamine
applied using SPT lancets [43] and using the approached outlined in [44] for crossover designs.
A α-level of 0.05, a power of 80%, and a least relevant difference of 20% were applied giving
rise to a minimum required sample size estimate of18. To account for potential dropout or
no-show a total of 20 subjects were recruited. Data is generally presented as arithmetic
means ± standard error of the mean (SEM), unless else is specifically stated. The obtained data
for wheal diameter were confirmed to be normally distributed within the various experimental
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conditions by visual inspection of Q-Q plots and frequency distribution. Additionally, all the
acquired metric data variables, apart from peak pain scores, were normally distributed, accord-
ing to the Shapiro-Wilk test. The obtained data for wheal diameter were tested by One-way
Repeated Measures ANOVA and a Tukey post-hoc test was used to observe inter-group differ-
ences and to correct for multiple comparisons. The obtained data for the superficial perfusion
were tested by using a paired sample t-test to observe the difference between the data from the
baseline (i.e. superficial blood-perfusion monitored by FLPI provides a baseline value) and the
obtained data after performing the SPT. To observe the difference between groups and correct
for multiple comparisons a Tukey post-hoc test was used. The collected data for the mean peak
pain VAS-score were tested by a Wilcoxon rank-sum test. For the qualitative data, the Chi-
square (Χ2) test was used to determine whether the number of pricks that caused bleeding inci-
dents were significantly associated with the applied lancet weight. For the data obtained in the
sub-experiment of SPT weight recordings in clinicians and for the applied lancet weights only
descriptive statistics were performed to elucidate data variability, i.e. the mean and the coeffi-
cient of variation (CV = standard deviation expressed as % of the mean). A p-value< 0.05 was
considered significant and marked with a single asterisk () in legends, while a p-value< 0.01
is marked with double asterisk ().
Results
All enrolled subjects (n = 20) completed the experiment with no serious and/or unexpected
adverse events. Only on two separate occasions did SPT with saline and a lancet weight of 265
g cause wheal reactions (<3 mm diameter). Subject no. 3 had a mean wheal diameter of 2 mm
on the forearm while subject no. 19 had a mean wheal diameter of 2 mm on the back after SPT
with saline. No wheal reactions occurred in response to saline in weights< 265 g. In this study,
no significant differences were observed in relation to gender or anatomical location of any of
the monitored reactions, however, since this was not the study objective, statistical powering
were likely inadequate for this purpose.
Applied SPT lancet weights
Applied SPT weights generally had very low variability. The mean and the CV for the peak of
the four pre-established lancet weights; 25 g, 85 g, 135 g and 265 g, are presented in Table 1.
Notice that a tendency towards higher applied weights on the back was observed particularly
for the 265 g condition.
Higher lancet weight causes larger wheal diameter
The mean wheal diameter increased significantly with higher lancet weights when applying his-
tamine regardless of concentration and anatomical location (see Fig 2A and 2B). Using a hista-
mine concentration of 10 mg/mL on the volar aspects of the forearms, a difference was seen in
Table 1. The mean and coefficient of variation (CV%), calculated as the ratio between the standard
deviation and the mean for the four predetermined peak lancet weights; 25 g, 85 g, 135 g and 265 g at
the forearm and back. Data for applied lancet weight are pooled for conditions with saline, 1 mg/mL of hista-
mine and 10 mg/mL of histamine. Notice that the deviation is proportionally higher in the 25 g weight group.
Location Weights
25 g 85 g 135 g 265 g
Forearm 26.3 (4.6%) 86.6 (1.7%) 133.2 (1.4%) 260.4 (1.5%)
Back 27.63 (2.2%) 89.9 (1.1%) 133.6 (1.2%) 270.0 (1%)
doi:10.1371/journal.pone.0156211.t001
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the mean wheal diameters between 25 g and the three other applied lancet weights; 85 g, 135 g
and 265 g (p< 0.01). Furthermore, a difference was observed in the mean wheal diameters
between the lancet weights of 85 g and 265 g, see Fig 2A. Oppositely, when applying saline no
significant difference in the mean wheal diameters was seen between the four lancet weights;
25 g, 85 g, 135 g and 265 g on the forearms nor on the back.
At a lancet weight of 25 g and a histamine concentration of 10 mg/mL the mean wheal
diameter on the volar forearm was 3.2 mm, however 4/20 subjects had a wheal diameter < 3
mm, thus not constituting positive reactions by most current guidelines [13,19]. The 99% CI
for the mean wheal diameter at a lancet weight of 25 g was 2.4–4.0 mm. However, the lancet
weights of 85 g, 135 g and 265 g resulted in lower boundaries of the 99% CI’s consistently> 3
mm. When applying a histamine concentration 1 mg/mL there was a difference in the mean
wheal diameter on the back between the lancet weight of 25 g and the other three used lancet
weights; 85 g, 135 g and 265 g (p< 0.01). Moreover, a difference was observed for the mean
wheal diameters between the lancet weights of 85 g and 265 g, see Fig 2B.
In addition, at a histamine concentration of 10 mg/mL a difference was found in the mean
wheal diameter between the lancet weight of 25 g and the other three used lancet weights 85 g,
135 g and 265 g (p< 0.01). Furthermore, a difference was seen between 85 g and 265 g and
between 135 g and 265 g, see Fig 2B. SPT on the back when applying histamine 10 mg/mL at a
lancet weight of 25 g resulted in a mean wheal diameter of 3.3 mm. However, 2/20 subjects had
a wheal diameter< 3 mm and the 99% CI for the mean wheal diameter was 2.9–3.9 mm. With
lancet weights 85 g the lower boundary of the wheal diameter 99% CI was always> 3 mm in
the 10 mg/mL group. A lancet weight of 135 g was required to consistently obtain a lower 99%
CI boundary> 3 mm when histamine 1 mg/mL was applied in the SPT on the back.
Fig 2. A) The mean wheal diameters on the forearms for each lancet weight; 25 g, 85 g, 135 g and 265 g. A higher lancet weight significantly increased
the sizes of the wheal reactions.B) The mean wheal diameters on the back for each lancet weight; 25 g, 85 g, 135 g and 265 g. A higher lancet weight
significantly increased the sizes of the wheal reactions. A significant difference was also observed when comparing the two histamine concentrations: 1
mg/mL and 10 mg/mL. For each condition; n = 20. * = p < 0.05, ** = p < 0.01. Mean ± SEM.
doi:10.1371/journal.pone.0156211.g002
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Higher lancet weight causes increased flare reactions
An increase in the mean superficial perfusion in accordance with increased weight when apply-
ing histamine 10 mg/mL was seen only from the lancet weight of 25 g to 265 g on the forearms
(p< 0.01) yet from the baseline a difference in the mean superficial perfusion was seen for all
used lancet weights; 25 g, 85 g, 135 g and 265 g, see Fig 3A.
A significant increase was observed in the mean superficial perfusion between the lancet
weights of 25 g and 265 g when applying 1 mg/mL versus 10 mg/mL histamine on the back.
Furthermore, a difference from baseline was found for 25 g, 85 g, 135 g and 265 g (p< 0.01)
both when applying histamine 1 mg/mL and histamine 10 mg/mL. Notice when applying
saline a difference was also seen from baseline levels to 265 g skin pricks (see Fig 3B).
Higher lancet weight causes increased occurrence of bleeding and
increased provoked pain perception
A higher lancet weight was found to cause more incidents of bleeding both on the forearms
and on the back (p< 0.01), see Fig 4A and 4B. Significant differences in incidents of bleeding
were found between 25 g and 135 g, 25 g and 265 g, 85 g and 135 g, 85 g and 265 g, and 135 g
and 265 g both on the forearms and on the back (see Fig 4A and 4B). Furthermore, no differ-
ences were observed when comparing the number of incidents of bleeding on the forearms
with the number of incidents of bleeding on the back.
Expectedly, higher lancet weights were associated with increased, albeit still only mild, pain.
A difference in the mean peak VAS-score for pain was seen between 25 g and the three other
applied lancet weights; 85 g, 135 g and 265 g. Moreover, a difference between 85 g and 265 g
Fig 3. A)Changes in the mean superficial perfusion on the forearms according to the lancet weights: 25 g, 85 g, 135 g and 265 g. A difference in the
mean superficial perfusion was seen from baseline to all the four applied lancet weights.B)On the back a difference in the mean superficial perfusion was
seen from baseline to all the four applied lancet weights with both histamine concentrations (1 mg/mL and 10 mg/mL) and from baseline for the lancet
weight of 265 g with saline as well. For each condition; n = 20. * = p < 0.05, ** = p < 0.01. Asterisks (*) or (**) placed just above the bars indicates
significant difference from baseline superficial skin perfusion. Mean ± SEM.
doi:10.1371/journal.pone.0156211.g003
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was found, see Fig 4C. No significant difference was observed in the peak pain between the
arms and the back.
Preliminary data suggest clinical staff exert SPT lancet weights
characterized by high inter-variability
From sampling in a small cohort of clinicians working with SPT the preliminary data suggests
that inter-reliability is poor, varying between 29 g and 367 g of weight (mean CV = 81%), see
Fig 5A. However, intra-reliability is generally better, particularly for clinician no. 1 and no. 3,
see Fig 5B.
Discussion
The present study shows that higher SPT lancet weights increase the mean diameter of wheals,
intensify the flare, increase the peak lancet provoked pain, and causes more frequent bleedings.
Additionally it was elucidated that lancet weights of 25 g is generally insufficient to reliably
induce adequate positive wheal responses (i.e.> 3 mm in diameter according to most current
guidelines [13]) while 85 g of lancet weight was found to be sufficient. Ideally the SPT proce-
dure should be without false negative and false positive results, give rise to no adverse events,
entail limited patient discomfort and generally not result in bleeding [13,19,27,35,38,42]. To
pursue the ideal SPT protocol the variables related to the procedure should be adequately opti-
mized and controlled, e.g. the prick device geometry, the concentration of allergens (and hista-
mine) and the applied lancet weight are three frequently mentioned parameters [35,39]. Of the
three parameters both composition of allergens and lancet design have received significant
attention [1,33,35,40,45], while this study is the first to quantify lancet weight in relation to
Fig 4. The percentage distribution of bleeding incidents in response to individual SPTs when using the four lancet weights; 25 g, 85 g, 135 g
and 265 g at A) the arm andB) the back, regardless of the applied solution (saline, 1 mg/mL histamine or 10 mg/mL histamine). A higher lancet weight
caused increased incidents of bleeding. C) Peak pain intensity in response to the four lancet weights for both arm and back rated on a coVAS. The peak
pain intensity increased significantly with increased weight. Notice that pain during SPT, regardless of weight, remains negligible, i.e. < 8 on a 0–100 VAS
(N.B.: discrete x-axis is applied for graph C). For each condition; n = 20. * = p < 0.05, ** = p < 0.01. C) Mean ± SEM.
doi:10.1371/journal.pone.0156211.g004
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skin reactivity. The current study indicates an usefulness of locking lancet weight in a predeter-
mined ideal range (presumably between>25 g and<85 g using 10 mg/mL histamine) or
adjusting lancet weight when training to perform SPT in the clinic. By doing so, it should be
possible to reduce false positive and false negative results and additionally limit pain and inci-
dents of bleeding. However, further research is warranted and this study is not exempt from
limitations. Particularly, the present study did not apply allergens but histamine (commonly
Fig 5. A) Shows individual lancet peak weight measurements from four different clinicians (no. 1–4). The horizontal lines denote the arithmetic mean for
each individual. B) Shows intra-reliability and inter-reliability (dotted horizontal line) of applied weight expressed as the coefficient of variation (standard
deviation expressed as % of the mean) for each of the four testees and between the four testees. CV% = Coefficient of variation (calculated as the ratio
between the standard deviation and the mean in %).
doi:10.1371/journal.pone.0156211.g005
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used as a positive control). This sidesteps the mast-cell degranulation process and it is
unknown whether SPT reactions to actual allergens could potentially be less susceptible to
aggravation by increased lancet weight. Lastly, it should be noted, that for the preliminary data
subset recorded amongst the four clinicians, it has not been assessed to which extend the skin
prick weight delivered to the Somedic weight transducer correlates with the skin prick weight
delivered on human skin. On the other hand this study was conducted in a homogenous group
of young healthy controls, wherein SPT responses were unambiguously intensified by higher
lancet weight. In clinical practice a number of uncontrollable variables are known to affect SPT
including, gender, age, ethnicity and season [20,26,27], thus making it highly desirable to adjust
for as many influencing controllable factors as possible.
Higher lancet weight is associated with larger wheals, increased
frequency of bleeding and more pain
A few previous studies have probed the frequently held notion of lancet weight as being impor-
tant for the SPT procedure, but no studies until now have quantified various SPT lancet weights
and their resultant skin responses. A study by Phagoo et al. (1991) actually elucidated that
weight could be a vital parameter in SPT by using undefined: “light”, “moderate”, and “hard”
application weights and subsequently monitoring wheal reactions. However, the study failed to
quantify both the used weight ranges and the individual weight application groups, making the
results very limited in terms of extrapolatability [39]. Østerballe et Weeke (1979) showed that an
increased prick depth correlated with an increased wheal diameter [40] contributing to the
development of the 1 mm shouldered SPT lancet. Since histamine acts on the local vascular
layer [46] it should be exposed localized to the micro-vascular system with the upper plexus
approximately 1–1.5 mm below the upper layer of epidermis [47,48]. The present study showed
a significant stepwise increase in the mean wheal diameter in response to higher lancet weights
when applying histamine. That is, despite using a standardized shouldered, 1 mm tip lancet
design, higher lancet weights ( 265 g) are still likely to drastically increase tissue exposure [39]
resulting in larger skin reactions, bleedings [40] and an increased risk of false positives [8,13,35]
while very low lancet weight, i.e. 25 g inadequately exposes tissue to histamine (and likely
allergens) resulting in insufficient SPT reactions or in clinical practice; false negatives.
Furthermore, when performing SPT a secondary goal is to reduce patient discomfort such
as pain [1,35]. As inherently expected [49,50], higher lancet weight significantly increased the
pain experienced during the SPT procedure. By predetermination of an optimal lancet weight,
which allows for high diagnostic sensitivity and specificity, unnecessarily high lancet weights
(see Fig 5A and 5B) can be avoided, thus reducing the associated pain. This study warrants fur-
ther research of the optimal lancet weight where the incidents of bleeding are as low as possible
while still resulting in a positive wheal diameter> 3 mm. Based on the present results, a lancet
weight in the range of> 25 g and 85 g seems to satisfy most practical clinical criteria for an
ideal SPT procedure.
Perspectives
Higher lancet weights are positively associated with several unwanted aspects of SPT such as
patient discomfort, risk of adverse events (although rare in response to SPT they do occur
[51,52]), blood drawing and likely the incidence of false positives. Based on the findings of this
study it is inherent to infer that a standardized SPT lancet weight could be within an optimum
range balancing between false negative reactions and unwanted effects. This challenge could be
overcome in the clinical setting either by supplying clinicians performing SPT with small gauge
allowing them to periodically calibrate their exerted lancet weight. Another option is to use a
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small pinprick stimulator with a mount for detaching/attaching SPT lancet at a specific prede-
termined weight, e.g. as depicted on Fig 6. Further testing is needed to assure the feasibility of
both approaches stated above.
The fact that increased lancet weights precipitates aggravated physiological responses, most
prominently increases wheal and flare seems inherently logical and is likely a consequence sim-
ply of increased tissue exposure to, in this case, histamine. Despite it being a variable previously
mentioned in the literature [1,13,38] this study is the first to quantitatively elucidate lancet
weight as a potentially biasing variable and to document to which extent it influences SPT
responses. In conclusion, with the presented limitations, this study provides novel and unam-
biguous evidence that higher lancet weights are associated with larger mean wheal diameters.
This pose an important question for further investigation: can the lancet weight turn a true
negative SPT to an allergen into a false positive or a true positive into a false negative and thus
directly influence diagnosis?
Supporting Information
S1 File. Allocation schedules and anatomical setup for skin prick testing. Images 1–20
depict allocation of the areas and substances of skin prick testing on the volar aspect of the
forearm and on the back.
(DOCX)
Fig 6. Weighted SPT lancet device.Depicts a suggested mechanical approach to a locked weight device
allowing for SPT within a specific predetermined weight.
doi:10.1371/journal.pone.0156211.g006
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S1 Table. An overview of international skin prick testing guidelines. An outline of various
skin prick test guidelines.
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